DNB Fund-Health Care Retail A (EUR)

Reference Data

ISIN LU1660425346
Valor Number 37774288
Bloomberg Global ID
Fund Name DNB Fund-Health Care Retail A (EUR)
Fund Provider DNB Asset Management AS Stockholm, Sweden
Phone: +46 8 473 41 00
Web: www.cim.se
Fund Provider DNB Asset Management AS
Representative in Switzerland FundPartner Solutions (Suisse) SA
Genève 75
Distributor(s) Allfunds International Schweiz AG DZ Private Bank (schweiz) AG Fund Channel (Suisse) SA
Nyon 2
Phone: +4122 0000 Swissquote Bank
Gland
Phone: +41 22 999 94 11 UBS AG
Zürich
Phone: +41 44 234 11 11
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition The fund does not charge any issuing commission and/or fees (units are issued at the NAV)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** Emphasis is placed on investments in the equities of companies operating in or associated with the health care sectors. Geographically the Sub-Fund has full flexibility. The Sub-Fund may invest between 5% and 15% of its net assets in equities quoted on the Hong Kong Stock exchange or on the Shanghai Stock exchange.
Peculiarities

Fund Prices

Current Price * 14.95 EUR 30.06.2025
Previous Price * 14.95 EUR 27.06.2025
52 Week High * 18.37 EUR 30.08.2024
52 Week Low * 14.83 EUR 22.04.2025
NAV * 14.95 EUR 30.06.2025
Issue Price * 14.95 EUR 30.06.2025
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 97,065,947
Unit/Share Assets *** 172,980
Trading Information SIX

Performance

YTD Performance -11.87% 31.12.2024
30.06.2025
YTD Performance (in CHF) -12.39% 31.12.2024
30.06.2025
1 month -1.97% 30.05.2025
30.06.2025
3 months -10.01% 31.03.2025
30.06.2025
6 months -11.50% 30.12.2024
30.06.2025
1 year -14.85% 01.07.2024
30.06.2025
2 years -8.34% 30.06.2023
30.06.2025
3 years -5.27% 30.06.2022
30.06.2025
5 years +13.81% 30.06.2020
30.06.2025

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Eli Lilly and Co 7.05%
AstraZeneca PLC 6.45%
Roche Holding AG 6.22%
Novo Nordisk AS Class B 6.15%
Johnson & Johnson 6.03%
Lonza Group Ltd 3.77%
UnitedHealth Group Inc 3.48%
Sanofi SA 3.26%
DexCom Inc 3.24%
Thermo Fisher Scientific Inc 3.03%
Last data update 31.05.2025

Cost / Risk

TER *** 1.605%
TER date *** 31.03.2025
Performance Fee *** 20.00%
PTR
Max. Management Fee *** 1.50%
Ongoing Charges *** 1.60%
SRRI ***
SRRI date *** 31.05.2025

Breakdowns

Equity Countries ***

Equity Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)